新闻
2023-10-19
并购
2023-10-18
FDA Approves XPHOZAH® (tenapanor), a First-in-Class Phosphate Absorption Inhibitor
临床结果临床3期上市批准引进/卖出
2023-10-18
基因疗法临床3期
2023-10-18
Jay Glazer Teams Up with Supernus Pharmaceuticals to Raise Awareness of ADHD and his Qelbree® Journey
2023-10-18
Fortress Biotech Subsidiary Helocyte Announces Option Agreement with City of Hope for Exclusive Worldwide Rights to use a Novel Bispecific CMV/HIV CAR T Cell Therapy (optionally in combination with Triplex) for the Treatment of Adults Living with HIV-1
临床2期疫苗免疫疗法临床1期细胞疗法
2023-10-17
Notable Labs Closes Merger Transaction With VBL Therapeutics
临床2期并购高管变更孤儿药
2023-10-16
并购
2023-10-13
SELLAS Life Sciences Provides Update on Phase 3 REGAL Clinical Trial for Galinpepimut-S in Acute Myeloid Leukemia
临床3期
2023-10-13
Optimind Pharma Announces Entry Into Acquisition Agreement With Wolf Acquisitions
并购
2023-10-12
RVL Pharmaceuticals plc Announces Prepackaged Reorganization of Certain U.S. Subsidiaries
并购上市批准